Dow Up1.47% Nasdaq Up1.65%

Theravance Inc. (THRX)

-NasdaqGS
17.18 Up 0.20(1.18%) 3:01PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 165   1,648   466   1,300  
Cost of Revenue188   -   -   -  
Gross Profit (23) 1,648   466   1,300  
Operating Expenses
Research Development43,387  33,631  87,099  (21,965)
Selling General and Administrative22,834  16,469  20,107  3,549  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (66,244) (48,452) (106,740) 19,716  
Income from Continuing Operations
Total Other Income/Expenses Net185  209  156  8,382  
Earnings Before Interest And Taxes(66,059)(48,243)(106,584)28,098  
Interest Expense1,644  1,686  1,901  3,025  
Income Before Tax(67,703)(49,929)(108,485)25,073  
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(67,703)(49,929)(108,485)25,073  
Non-recurring Events
Discontinued Operations -   -  61,502  (61,502)
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (67,703) (49,929) (46,983) (36,429)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (67,703) (49,929) (46,983) (36,429)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.